Tag: SDH
SNIS acknowledges “major shift” in chronic SDH treatment following new trial...
In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic...
Addition of MMA embolisation reduces haematoma recurrence or progression in MAGIC-MT...
The use of middle meningeal artery (MMA) embolisation alongside standard care has been deemed superior to standard care alone for patients with symptomatic, non-acute...
STEM study finds improved outcomes with MMA embolisation over standard care...
Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared...
MMA embolisation plus surgery reduces risk of subdural haematoma recurrence in...
Middle meningeal artery (MMA) embolisation—the injection of a liquid embolic substance to block an artery feeding the brain’s dura—along with surgery for subacute or...
RapidAI receives US FDA clearance of AI module for detecting hemispheric...
RapidAI announced today that it has received US Food and Drug Administration (FDA) clearance for Rapid SDH, its artificial intelligence (AI)-powered module for the detection...
Craniotomy and decompressive craniectomy achieve similar outcomes in acute subdural haematoma
The two prevailing techniques used during surgical treatments of traumatic acute subdural haematomas (SDHs)—craniotomy and decompressive craniectomy—have demonstrated broadly similar efficacy outcomes in a...
IRRAflow system leads to favourable clinical outcomes versus passive drainage in...
IRRAS has announced the publication of the first comparative study detailing the use of the company's novel IRRAflow system. This study, which was conducted under the...
